Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes
The American Journal of Managed Care · 21.02.2023 · 29 (2) · e43-e50
DOI: 10.37765/ajmc.2023.89320 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, online erschienen am 21.02.2023. Verfasst von Benjamin D Lewing und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Houston, 4849 Calhoun, HB2, R4058, Houston, TX 77204-5047. Email: BLewing2@central.uh.edu. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Influenza, Human.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Houston, 4849 Calhoun, HB2, R4058, Houston, TX 77204-5047. Email: BLewing2@central.uh.edu.
Zitieren
APA
Lewing, B. D., Wallick, C., To, T. M., Masters, H., Dayal, P., Korom, S. W., & Tam, S. (2023). Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes. The American Journal of Managed Care, 29(2), e43-e50. https://doi.org/10.37765/ajmc.2023.89320
Vancouver
Lewing BD, Wallick C, To TM, Masters H, Dayal P, Korom SW, et al. Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes. The American Journal of Managed Care. 2023;29(2):e43-e50. doi:10.37765/ajmc.2023.89320
BibTeX
@article{Lewing2023,
author = {Lewing, Benjamin D and Wallick, Christopher and To, Tu My and Masters, Henry and Dayal, Parul and Korom, Stephan W and Tam, Selina},
title = {Outcomes of Antiviral Treatment for Influenza in Type 2 Diabetes},
journal = {The American Journal of Managed Care},
year = {2023},
volume = {29},
number = {2},
pages = {e43--e50},
doi = {10.37765/ajmc.2023.89320}
}
EUVIMED